Floatz logo

Therapeutic Asset Ratings

6,538 results matching 1 filter

133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
TRASTUZUMAB
Recurrent Bladder Cancer
NKGen Biotech, Inc.P2BB (70)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Breast Cancer
SWOG Cancer Research NetworkP4BB (69)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Primary Central Nervous System Lymphoma
Ono Pharmaceutical Co., Ltd.P4BB (69)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Recurrent Childhood Acute Lymphoblastic Leukemia
Peking Union Medical College HospitalP4BB (69)
Ipilimumab
Melanoma
M.D. Anderson Cancer CenterP4BB (69)
Ipilimumab
Metastatic Kidney Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (69)
Nivolumab
Lung Cancer
University of ChicagoP4BB (69)
Nivolumab
Melanoma
Bristol-Myers SquibbP4BB (69)
Nivolumab
Non Small Cell Lung Cancer
Fred Hutchinson Cancer CenterP4BB (69)
Nivolumab
Renal Cell Carcinoma
Fred Hutchinson Cancer CenterP4BB (69)
Pembrolizumab
Melanoma
Biocon Biologics UK PLCP4BB (69)
Pembrolizumab
Metastatic Kidney Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCSP4BB (69)
Tislelizumab
Non Small Cell Lung Cancer
CSPC Megalith Biopharmaceutical Co.,Ltd.P4BB (69)
Cetuximab
BRAF V600E-mutated /MSS Metastatic Colorectal Cancer
Fujian Cancer HospitalP3BB (69)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Colon Cancer Stage III
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (69)
IMMUNOGLOBULIN G1, ANTI-(HUMAN NEU (RECEPTOR)) (HUMAN-MOUSE MONOCLONAL 2C4 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2C4 .KAPPA.-CHAIN, DIMER
Recurrent Colon Carcinoma
IFOM ETS - The AIRC Institute of Molecular OncologyP3BB (69)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER
Lymphoplasmacytic Lymphoma
Memorial Sloan Kettering Cancer CenterP3BB (69)
Ipilimumab
Clinical Stage III Cutaneous Melanoma AJCC v8
Amsterdam UMC, location VUmcP3BB (69)
Ipilimumab
Clinical Stage IV Cutaneous Melanoma AJCC v8
Amsterdam UMC, location VUmcP3BB (69)
Obinutuzumab
Chronic Lymphocytic Leukemia
M.D. Anderson Cancer CenterP3BB (69)
Pembrolizumab
Esophageal Carcinoma
NuCana plcP3BB (69)
Tislelizumab
Hepatic Metastasis of Pancreatic Cancer
Ruijin HospitalP3BB (69)
Alcestobart
NSCLC for Phase 2 Dose Expansion
BeiGeneP2BB (69)
Atezolizumab
HER2 Negative
TransThera Sciences (Nanjing), Inc.P2BB (69)
Cetuximab
Rectal Cancer
Tang-Du HospitalP2BB (69)
Showing 101 to 125 of 6,538 assets
PreviousPage 5 of 262Next